Generic Advent DT

Common use

Advent DT is a broad-spectrum antibiotic used to treat various bacterial infections, including those affecting the respiratory tract, urinary tract, skin, ear, and soft tissues. It combines Amoxicillin, a penicillin-type antibiotic that kills bacteria, with Clavulanic Acid, which inhibits beta-lactamase enzymes that make bacteria resistant to antibiotics. This combination enhances effectiveness against resistant strains. The DT (dispersible tablet) formulation is especially suited for children and those with difficulty swallowing.

Dosage and direction

Advent DT should be taken as prescribed by a healthcare provider, usually every 8 or 12 hours, depending on the severity and type of infection. The tablet must be dissolved in a small amount of water and taken immediately after mixing. Dosage is typically based on weight and age, especially in pediatric cases. Complete the full course even if symptoms improve early to prevent resistance.

Precautions

Before using Advent DT, inform your doctor if you have a history of liver disease, kidney problems, or allergic reactions to penicillins or cephalosporins. Use with caution in patients with phenylketonuria (PKU) due to aspartame content in some formulations. Monitor for allergic reactions or gastrointestinal symptoms during treatment. It should not be used to treat viral infections such as flu or the common cold.

Contraindications

Advent DT is contraindicated in individuals with a known allergy to amoxicillin, clavulanic acid, or other beta-lactam antibiotics. It should not be used in patients who have experienced jaundice or liver dysfunction associated with this combination in the past. It is also not recommended for neonates unless directed by a doctor. Always consult a healthcare provider before starting this medication.

Possible side effect

Common side effects may include diarrhea, nausea, vomiting, abdominal pain, and skin rash. Less commonly, patients may experience yeast infections, liver enzyme changes, or allergic reactions like itching or swelling. Rare but serious effects include severe skin reactions or anaphylaxis. Contact your doctor if you notice persistent diarrhea or signs of liver problems like yellowing of the skin or eyes.

Drug interaction

Advent DT may interact with oral anticoagulants (e.g., warfarin), allopurinol, and methotrexate, potentially increasing the risk of adverse effects. It may also reduce the effectiveness of oral contraceptives. Inform your doctor about all prescription, non-prescription, and herbal products you are using. Avoid taking with alcohol as it may increase stomach upset.

Missed dose

If a dose is missed, take it as soon as you remember. If it’s almost time for the next dose, skip the missed one — do not double up to compensate. Try to maintain consistent intervals between doses. Irregular dosing can reduce the effectiveness of the treatment.

Overdose

Symptoms of overdose may include severe gastrointestinal distress, seizures, or kidney dysfunction, especially in patients with preexisting kidney issues. In case of overdose, seek immediate medical assistance. Treatment typically involves supportive care and hydration. Always follow the prescribed dose to avoid complications.

Storage

Store Advent DT at room temperature (15–25°C / 59–77°F), away from moisture and direct sunlight. Do not refrigerate or freeze. Keep the medication in its original packaging until use. Keep out of reach of children and pets.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Clinical Verification

Last Clinically Updated: August 15, 2026

Written By

Dr. Elena Vance, PharmD

Clinical Specialist in Neuropharmacology

Fact Checked By

Marcus Thorne, MS

Biomedical Data & FDA Label Verification

Medically Reviewed By

Dr. Arthur Campbell, MD

Board-Certified Psychiatrist (ABPN)